top of page

Alectinib

Alectinib is a 2nd generation TKI developed by Roche. The recommended dose is 600mg taken twice daily. Along with Brigatinib, Alectinib is the usual first line treatment for newly diagnosed ALK-positive lung cancer patients

New

Alectinib
and
Diet

Capture weight.PNG

Alectinib
and
weight gain

Rash Pic.JPG

Alectinib- induced Rash
Case History

Alectinib
Dose Reduction
& Side Effects

Capture alec dosage.PNG

Alectinib
Safety of dose
escalation

Anyone with lungs can get lung cancer.

bottom of page